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EDITORIAL
CLC-5 chloride channels and renal disease
In this issue of Kidney International, Kelleher et al [1], describe
a family of forty-eight individuals in three generations, five of
whose male members developed hypercalciuria, nephrocalcinosis,
nephrolithiasis, proteinuria and renal failure at an early age.
Clinically, none of the affected patients had rickets or osteoma-
lacia. Genetic analysis showed that the affected males had a C3T
transition in exon 6 of the CLCN-5 chloride (Cl) channel gene,
resulting in the expression of a CLC-5 Cl channel with reduced
function. The base change in the CLCN-5 gene altered a serine
residue at position 244 in a hydrophobic stretch of the protein to
a leucine residue. Six women who were identified as carriers had
intermittent hypercalciuria and low molecular weight proteinuria.
The same S244L mutation is found in patients with XLRH, a
related disease with prominent rickets. This report expands the
spectrum of phenotypic features found in patients with mutations
of the CLCN-5 gene and suggests that genetic, dietary or environ-
mental factors alter disease features in patients with such mutations.
Four diseases, with similar but not identical phenotypes,
namely, Dent’s disease, X-linked recessive nephrolithiasis with
renal failure (XRN), X-linked hypophosphatemic rickets
(XLRH) and low molecular weight proteinuria with hypercalci-
uric nephrolithiasis, have been described [2–6]. Initially, Dent and
Friedman [2], and later Wrong et al [3], described “a familial form
of Fanconi syndrome, characterized by low-molecular proteinuria,
hypercalciuria, nephrocalcinosis, progressive renal failure and a
marked male predominance.” Hypophosphatemia, a reduced Tm
for phosphate, and clinical rickets were found in several of the
affected subjects. Frymoyer et al [4], reported a family, the male
members of which had many of the features of Dent’s disease but
no rickets or bone disease. The mode of inheritance was felt to be
X-linked recessive, and hence the acronym XRN. A related
disease, X-linked hypophosphatemic rickets or XLRH, has fea-
tures of Dent’s disease but more marked nephrocalcinosis and
moderate renal failure [5]. Finally, there has been a recent
description of a disease in Japanese children characterized by low
molecular weight proteinuria, and hypercalciuric nephrocalcinosis
but no renal failure [6]. The patients in the family described by
Kelleher et al [1], have features of Dent’s disease, X-linked
transmission but no rickets or osteomalacia.
Dent’s disease was shown to be associated with mutations in the
chloride channel gene, CLCN-5 [7, 8]. Lloyd et al [9], showed that
Dent’s disease, XRN and XLRH are all associated with mutations
of the CLCN-5 gene. Dent’s disease is associated with mutations
W279X, R648X, L200R, S520P, two microdeletions and two
donor splice site mutations; XRN with R704X and G506E
mutations; XLRH a S244L mutation; and low molecular weight
proteinuria with hypercalciuric nephrolithiasis with W279X,
R280P, W343X and a D695fs3699Stop mutations or frame shifts
[11]. When expressed in Xenopus oocytes, most mutant Cl channel
proteins do not generate Cl currents; the S244L and S520P
mutants generate greatly diminished currents.
A key issue is to understand how alterations in CLC-5 function
alter the transport of calcium and low molecular weight proteins
in the kidney. Three classes of Cl channels have been character-
ized: the first class is exemplified by the glycine and GABAA
receptors; the second is typified by the cystic fibrosis transmem-
brane conductance regulator or CFTR; and the third includes the
CLC family of Cl channels [10]. Chloride channels are variously
regulated by cAMP, glycine, GABA, G-proteins, calcium, stretch
or voltage [10]. Plasma membrane, CLC Cl channels (CLC-1
through CLC-7, CLC-Ka and CLC-Kb), are widely distributed in
various cells and play a role in transepithelial transport, and the
control of neuronal and muscle excitability and cell volume [10].
CLC proteins have 13 hydrophobic regions, 11 of which may be
intra-membranous. Domains D-4 and D-13 are thought to lie
outside and inside the cell, respectively. CLC-1 channel mutations
are associated with myotonia.
Despite extensive information on Cl channel, structure and
regulation, there are no clear answers available as to how CLC-5
functions in the kidney. In Xenopus oocytes, CLC-5 elicits a Cl
current only at voltages in excess of 120 mV. It is unlikely that
such voltages are obtained in kidney cells and therefore it is hard
to visualize precisely how these channels work in renal cells. It is
possible that CLC-5 channels do not assemble in Xenopus oocytes
in a manner analogous to that found in mammalian kidney cells
and perhaps they do gate at physiological voltages in kidney cells.
The messenger RNA for rat CLC-5 is widely distributed along the
nephron [11]. CLC-5 mRNA is present in segments of the
nephron where protein and calcium transport occur [12] and it is
likely that mutant Cl channels, in some yet to be defined manner,
interfere with transport of these substances. It has been suggested
that in endosomes, Cl channels are necessary for dissipation of the
electrical gradient generated as a result of vacuolar hydrogen
ATPase activity. If CLC-5 channels exist in endosomes, mutations
in CLC-5 could interfere with transcellular protein movement by
altering endosomal function. Kelleher et al [1] speculate that this
may be the case, and invoke Tamm-Horsfall protein in this
process. Information on the subcellular localization of the protein
will determine whether this could be true. Consideration should
also be given to whether CLC-5 Cl channels are involved in the
modulation of renal injury as renal failure is a prominent part of
these disease states. Much will be learned by examining the
subcellular distribution of the various Cl channel proteins when
specific antibodies become available. The culture of cells derived
from the kidney of patients with these diseases and an examina-
tion of their properties might yield additional useful information.
Finally, the generation of a CLC-5 null mutant mouse may yield
interesting information on how Cl, protein and calcium interact in
the kidney.
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